Stay updated on N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Sign up to get notified when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.

Latest updates to the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study page shows reorganized sections and updated styling, while the underlying content (inclusion criteria, outcomes, and contact details) remains unchanged.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded a new site revision banner 'Revision: v3.4.2'. Removed the prior funding status notice and the older 'Revision: v3.4.1' banner.SummaryDifference0.5%

- Check41 days agoChange DetectedA government funding lapse notice and status banner was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedUI and metadata updates (glossary toggle, QC status wording update, and revision to v3.4.0) occurred, with the older QC wording and 'No FEAR Act data' text removed, and no changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedA new recruitment location in Tianjin Municipality has been added to the study.SummaryDifference0.2%

Stay in the know with updates to N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.